Legal Representation
Attorney
Steven M Hoffberg
USPTO Deadlines
Next Deadline
99 days remaining
NOA E-Mailed - SOU Required
Due Date
May 04, 2026
Extension Available
Until November 04, 2026
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 4, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 9, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 9, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 3, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 8, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 8, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Aug 8, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 8, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 8, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 15, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 14, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 14, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 14, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 14, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 14, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 17, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 8, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 5, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicinal drinks; Medicinal herb extracts, other than essential oils; Medicinal herbal extracts for medical purposes, other than essential oils; Medicinal herbal preparations; Medicinal herbs; Medicinal herbs in dried or preserved form; Medicinal oils, other than essential oils; Medicinal tea; Anti-inflammatory preparations; Beverages containing cannabis extract, cannabigerol, cannabigerolic acid for use as a nutritional supplement; Decoctions of medicinal herb; Dietary supplement beverage for treatment of neurological diseases, seizures, inflammation, viral infection, diabetes, metabolic disorders, free radical excess; Dietary supplements also containing cannabis oil, other than essential oils; full spectrum cannabis herb extract in the nature of concentrated components of cannabis plant for medical purposes, other than essential oils; Dietary supplements consisting primarily of cannabis oil, other than essential oils; Dietary supplements for human beings; Dietary supplements for human consumption; Dietary supplements for treatment of insomnia, sleep disorders, depression, anxiety, neurodegenerative diseases, Alzheimer's disease, dementia, Parkinson's disease, post traumatic stress disorder, phobias, addictions, attention deficit hyperactivity disorder, autism, mood disorders, brain disorders, central nervous system disorders; Dietary supplements in the form of cannabis extract oil, other than essential oils, for medical purposes; Dietary and nutritional supplements containing panakeia extract in the nature of powder, oil and solution for medical purposes, other than essential oils; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary fiber for treating constipation; Dietary fiber for use as an ingredient in the manufacture of dietary supplements; Dietary food supplements; Dietary supplements; Dietary supplements for humans; Food supplements for treatment of neurological diseases, seizures, inflammation, viral infection, diabetes, metabolic disorders, free radical excess; Health food supplements; Herb tea for medicinal purposes; Herbal extracts for medical purposes, other than essential oils; Herbal supplements; Herbal tea for medicinal purposes; Liquid herbal supplements; Liquid nutritional supplement; Medicinal roots; Natural herbal supplements; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for treatment of insomnia, sleep disorders, depression, anxiety, neurodegenerative diseases, Alzheimer's disease, dementia, Parkinson's disease, post traumatic stress disorder, phobias, addictions, attention deficit hyperactivity disorder, autism, mood disorders, brain disorders, central nervous system disorders; nutritional supplements for the treatment of neurological diseases, seizures, inflammation, viral infection, diabetes, metabolic disorders, free radical excess; Nutritional supplements; Nutritional supplements consisting primarily of cannabis oil, other than essential oils; Nutritional supplements for treatment of neurological diseases, seizures, inflammation, viral infection, diabetes, metabolic disorders, free radical excess; Nutritional supplements for treatment of insomnia, sleep disorders, depression, anxiety, neurodegenerative diseases, Alzheimer's disease, dementia, Parkinson's disease, post traumatic stress disorder, phobias, addictions, attention deficit hyperactivity disorder, autism, mood disorders, brain disorders, central nervous system disorders; Nutritional supplements in the form of oil other than essential oils, ground seeds, capsules, gelcaps; Nutritional food additives for medical purposes in the nature of natural food extracts derived from cannabis; Plant and herb extracts for medicinal purposes, other than essential oils; Plant and herb extracts for medicinal purposes, other than essential oils, sold as components of medicated cosmetics; Plant extracts for medical, veterinary and pharmaceutical purposes, other than essential oils; Plant extracts for pharmaceutical purposes, other than essential oils; all of the foregoing cannabis-related goods containing cannabis ingredients solely derived from hemp with a delta-9-tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and containing no CBD
Classification
International Classes
005